Escano Volquez Luis Miguel, Kanuri Sri Harsha, Haddad Roger
Henry Ford Hospital, Detroit, MI.
Pain Med Case Rep. 2024 Nov;8(7):249-252.
Infection with COVID-19 has evolved from a novel health crisis into an entity with a myriad of increasingly recognized sequelae. Among these, peripheral neuropathy is often an underrecognized and underdiagnosed complication. Neuropathic pain can be challenging to treat with many cases being refractory to conservative management, often requiring advanced techniques. Neuromodulation has become an important tool for the treatment of the refractory cases.
We present a case of a 43-year-old woman with refractory right tibial mononeuropathy secondary to COVID-19 infection who was treated successfully using peripheral nerve stimulation.
The use of peripheral neuromodulation represents a pivotal strategy for the management of difficult cases. Our case highlights the first use of neuromodulation to treat neuropathic pain secondary to COVID-19 infection. We hope that this case sparks further research on the topic, which could lead to better clarification of this condition and potential expansion of treatment strategies.
新型冠状病毒肺炎（COVID-19）感染已从一场新的健康危机演变成一种出现了无数日益得到认可的后遗症的疾病。其中，周围神经病变常常是一种未得到充分认识和诊断的并发症。神经性疼痛的治疗颇具挑战性，许多病例对保守治疗无效，往往需要采用先进技术。神经调节已成为治疗难治性病例的重要工具。
我们报告一例43岁女性患者，因COVID-19感染继发难治性右胫神经单神经病变，采用周围神经刺激治疗成功。
使用周围神经调节是处理疑难病例的关键策略。我们的病例突出了首次使用神经调节治疗COVID-19感染继发的神经性疼痛。我们希望这个病例能引发对该主题的进一步研究，从而更好地阐明这种疾病并可能扩展治疗策略。
